Simplex Trading
STIM icon

Simplex Trading’s Neuronetics STIM Stock Holding History

Simplex Trading’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390 Sell
300
-1,700
-85% -$2.47K ﹤0.01% 8990
2026
Q1 		$2.9K Sell
2,000
-5,100
-72% -$8.08K ﹤0.01% 8200
2025
Q4 		$9.8K Sell
7,100
-25,300
-78% -$52.9K ﹤0.01% 6994
2025
Q3 		$88K Buy
32,400
+16,100
+99% +$57.2K ﹤0.01% 5902
2025
Q2 		$56K Sell
16,300
-9,000
-36% -$35.5K ﹤0.01% 5816
2025
Q1 		$93K Buy
+25,300
New +$92.4K ﹤0.01% 5127
2021
Q4 		– Sell
-300
Closed -$4K – 11383
2021
Q3 		$4K Hold
300
– – ﹤0.01% 9360
2021
Q2 		$4K Buy
+300
New +$4.14K ﹤0.01% 9540

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Simplex Trading's STIM Position: Q2 2026 in Review

Simplex Trading increased its Neuronetics (STIM) stake by 5.6% in Q2 2026, buying an estimated $1.15K and bringing the position to 14,861 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #7133.

Simplex Trading first reported a position in STIM in Q1 2021 and has held it in 18 quarters since. The position peaked at $394K in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Simplex Trading held 14,861 shares of Neuronetics worth $19.3K as of Q2 2026.
  • Simplex Trading bought 788 Neuronetics shares in Q2 2026, an estimated $1.15K.
  • Neuronetics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7133 holding.
  • Simplex Trading first reported a position in Neuronetics in Q1 2021 and has held it in 18 quarters since.
  • Simplex Trading's Neuronetics position peaked at $394K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.